CVS brings back coverage for Lilly's obesity drug Zepbound ReutersFoundayo and Zepbound now covered for millions of Americans investor.lilly.comCVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans CNBCCVS Caremark will cover Lilly's weight loss drug Zepbound again after patient backlash NBC News
A Google engineer made $1.2 million by insider trading on Polymarket under the name 'AlphaRaccoon': DOJ Business InsiderFederal prosecutors charge Google engineer for allegedly using insider info to make $1.2 million on Polymarket CNNGoogle employee charged with $1M Polymarket insider trading bet on search term CNBCGoogle engineer made $1.2M by placing bets on Polymarket using confidential info, prosecutors allege NBC NewsGoogle worker charged with using internal data to make
